Thrombosis risk in purely obstetric APS

Blood

Volumn 119, Issue 11, 2012, Pages 2435-2436

  Simioni, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTIPHOSPHOLIPID SYNDROME; HETEROZYGOSITY; INCIDENCE; LOW DRUG DOSE; MORBIDITY; NOTE; PREGNANCY; PRIORITY JOURNAL; RECURRENT ABORTION; RISK ASSESSMENT; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84858696577     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-398735     Document Type: Note

References (10)

1. Gris JC, Bouvier S, Molinari N, et al. Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOHAPS observational study. Blood. 2012;119(11):2624-2632.
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.
3. Erkan D, Merrill JT, Yazici Y, Sammaritano L, Buyon JP, Loskshin MD. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum. 2001;44(6):1466-1467. (Pubitemid 32537548)
4. Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphopholipid antibodies: a four-year prospective study from the Italian registry. Am J Med. 1996;100(5):530-536. (Pubitemid 26170477)
5. Quenby S, Farquharson RG, Dawood F, HughesAM, Topping J. recurrent miscarriage and long-term thrombosis risk: a case-control study.HumReprod. 2005;20(6):1729-1732. (Pubitemid 40852272)
6. Giannakopoulos B, Krilis SA. How I treat antiphospholipid syndrome. Blood. 2009;114(10):2020-2030.
7. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidencebased clinical Practive Guidelines (8th Ed). Chest. 208;133(6 suppl):340S-380S.
8. Simioni P, Tormene D, Prandoni P, et al. Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood. 2002;99(6):1938-1942. (Pubitemid 34525472)
9. GalliM,Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factor for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101(5):1827-1832. (Pubitemid 36237580)
10. Pengo V, Ruffatti A, Legnani C, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high risk antiphospholipid antibody profile: a multicenter prospective study. Blood. 2011;118(17):4714- 4718.